FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

March 26, 2018

Primary Completion Date

October 29, 2018

Study Completion Date

October 29, 2018

Conditions
Hot Flashes
Interventions
DRUG

FP-101

Dose 1

DRUG

Placebo Comparator

Dose 1

Trial Locations (12)

27103

PMG Research of Winston-Salem, LLC, Winston-Salem

27518

PMG Research of Cary, LLC, Cary

27609

PMG Research of Raleigh, LLC, Raleigh

27804

Nash OB/GYN, Rocky Mount

28144

PMG Research of Salisbury, LLC, Salisbury

28209

PMG Research of Charlotte, LLC, Charlotte

28401

PMG Research of Wilmington, LLC, Wilmington

28601

PMG Research of Hickory, LLC, Hickory

29464

PMG Research of Charleston, LLC, Mt. Pleasant

37620

PMG Research of Bristol, LLC, Bristol

37830

PMG Research of Knoxville, Oak Ridge

61820

PMG Research of Christie Clinic, LLC, Champaign

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Fervent Pharmaceuticals

INDUSTRY

NCT03285672 - FP-101 for the Treatment of Hot Flashes in Postmenopausal Women | Biotech Hunter | Biotech Hunter